Whitebox Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Whitebox Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36,388	Closed	-$274K	–	953
2022 Q2	$274K	Sell	36,388 -129,385	-78%	-$1.13M	0.01%	519
2022 Q1	$1.56M	Buy	165,773 +87,531	+112%	+$730K	0.03%	232
2021 Q4	$627K	Buy	+78,242	New	+$706K	0.01%	454
2018 Q4	–	Sell	-31,050	Closed	-$669K	–	107
2018 Q3	$669K	Buy	+31,050	New	+$721K	0.02%	86
2015 Q2	–	Sell	-4,800	Closed	-$299K	–	397
2015 Q1	$299K	Buy	+4,800	New	+$279K	0.01%	316

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Whitebox Advisors's TEVA Position: Q3 2022 in Review

Whitebox Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 36,388 shares — an estimated $274K sold.

Whitebox Advisors first reported a position in TEVA in Q1 2015 and held it in 5 quarters. The position peaked at $1.56M in Q1 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Whitebox Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Whitebox Advisors sold 36,388 Teva Pharmaceuticals shares in Q3 2022, an estimated $274K.
Whitebox Advisors first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 5 quarters.
Whitebox Advisors's Teva Pharmaceuticals position peaked at $1.56M in Q1 2022.
430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Whitebox Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.